Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.82 +0.02 (+2.73%)
As of: Oct 2, 2026 · 9:56 AM EDT

Rani Therapeutics Holdings (RANI) Preferred Shares (2021)

Updated

Rani Therapeutics Holdings (RANI) posted Preferred Shares of $191.03 million for Q2 2021.

Analysis

Rani Therapeutics Holdings (RANI) Preferred Shares (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Rani Therapeutics Holdings 147.86 Mn 156.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 191.03 Mn
API Access

Rani Therapeutics Holdings Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=RANI&period=max&api_key=YOUR_API_KEY